Breast Cancer
Showing NaN - NaN of 156
Breast Cancer Trial in Pittsburgh (Radiation Therapy (RT))
Not yet recruiting
- Breast Cancer
- Radiation Therapy (RT)
-
Pittsburgh, PennsylvaniaUPMC Magee Womens Hospital - Radiation Oncology
Jul 14, 2022
Breast Cancer Trial in Pittsburgh (contrast enhanced mammography, Iodinated Contrast Media (ICM))
Recruiting
- Breast Cancer
- contrast enhanced mammography
- Iodinated Contrast Media (ICM)
-
Pittsburgh, PennsylvaniaUPMC Magee-Womens Hospital
Jul 6, 2022
Breast Cancer Trial in New York, Pittsburgh, Houston (Stereotactic Body Radiation Therapy (SBRT) (50GY in 5 fractions),
Recruiting
- Breast Cancer
- Stereotactic Body Radiation Therapy (SBRT) (50GY in 5 fractions)
- +2 more
-
New York, New York
- +4 more
Jun 29, 2022
Advanced or Metastatic Solid Tumors, Ovarian Cancer, NSCLC Trial in United States (NC762)
Recruiting
- Advanced or Metastatic Solid Tumors
- +3 more
-
New Haven, Connecticut
- +6 more
Jun 22, 2022
Breast Cancer Trial in United States (therapeutic conventional surgery, whole breast irradiation)
Active, not recruiting
- Breast Cancer
- therapeutic conventional surgery
- whole breast irradiation
-
Hot Springs, Arkansas
- +349 more
Jun 16, 2022
Oncology, Melanoma, Ovarian Cancer Trial in United States (E-602, Pembrolizumab)
Recruiting
- Oncology
- +16 more
- E-602
- Pembrolizumab
-
Grand Rapids, Michigan
- +4 more
May 27, 2022
HER2 Low and Describe SoC, Treatment Patterns, and Outcome in
Completed
- Breast Cancer
- None (Observational study)
-
Pittsburgh, Pennsylvania
- +12 more
May 25, 2022
Breast Cancer Trial in Worldwide (Amcenestrant-matching , SAR439859, Palbociclib)
Active, not recruiting
- Breast Cancer
- Amcenestrant-matching placebo
- +5 more
-
Daphne, Alabama
- +299 more
May 5, 2022
Breast Cancer Trial in United States (radiation, drug, biological)
Recruiting
- Breast Cancer
- Focal Radiation therapy
- +2 more
-
Los Angeles, California
- +6 more
Apr 29, 2022
Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (T-DXd), Ado-trastuzumab emtansine (T-DM1))
Active, not recruiting
- Breast Cancer
- Trastuzumab deruxtecan (T-DXd)
- Ado-trastuzumab emtansine (T-DM1)
-
Los Angeles, California
- +163 more
Apr 1, 2022
Proteomics and Radiomics Research of Breast Cancer Markers in
Recruiting
- Breast Cancer
-
Pittsburgh, PennsylvaniaUPMC St. Margaret
Apr 13, 2022
Breast Cancer Trial in Worldwide (Palbociclib, Standard Adjuvant Endocrine Therapy)
Active, not recruiting
- Breast Cancer
- Palbociclib
- Standard Adjuvant Endocrine Therapy
-
Mobile, Alabama
- +437 more
Mar 21, 2022
Colorectal Cancer (CRC), Endometrial Cancer, Melanoma Trial in United States (Pembrolizumab, itacitinib, INCB050465)
Completed
- Colorectal Cancer (CRC)
- +10 more
- Pembrolizumab
- +2 more
-
San Francisco, California
- +16 more
Mar 30, 2022
Breast Cancer Trial in United States (Trastuzumab, Paclitaxel, Trastuzumab emtansine)
Breast Cancer Trial in Worldwide (trastuzumab, docetaxel, lapatinib ditosylate)
Active, not recruiting
- Breast Cancer
- trastuzumab
- +3 more
-
Anchorage, Alaska
- +257 more
Feb 28, 2022
Neutropenia, Breast Cancer Trial in Canada, Korea, Republic of, United States (SPI-2012, Pegfilgrastim, Docetaxel)
Pancreatic Cancer, Thyroid Cancer, Lung Cancer Trial in United States
Recruiting
- Pancreatic Cancer
- +49 more
-
Colorado Springs, Colorado
- +80 more
Feb 22, 2022
Advanced Solid Tumors, Solid Tumors, Ovarian Cancer Trial in Australia, United States (TALZENNA capsule, Talazoparib soft gel
Active, not recruiting
- Advanced Solid Tumors
- +7 more
- TALZENNA capsule
- Talazoparib soft gel capsule
-
Encinitas, California
- +31 more
Feb 14, 2022
Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (DS-8201a), Capecitabine, Eribulin)
Active, not recruiting
- Breast Cancer
- Trastuzumab deruxtecan (DS-8201a)
- +5 more
-
Chandler, Arizona
- +207 more
Jan 25, 2022
Breast Cancer Trial in Worldwide (Abemaciclib, Standard Adjuvant Endocrine Therapy)
Active, not recruiting
- Breast Cancer
- Abemaciclib
- Standard Adjuvant Endocrine Therapy
-
Birmingham, Alabama
- +611 more
Jan 21, 2022
Breast Cancer, Breast Carcinoma, Breast Tumors Trial in Canada, United Kingdom, United States (Letrozole, palbociclib)
Completed
- Breast Cancer
- +2 more
-
Long Beach, California
- +51 more
Jan 4, 2022